1887

Abstract

SUMMARY

The indirect immunoferritin technique (IFT) that enables us to distinguish clearly whether an antibody reacts with a virus particle or only with the cell membrane, was used to study 25 cat sera and one rabbit anti-feline leukaemia virus (FeLV) serum using FL-74 cells as target. (1) All sera contained antibodies against FeLV even though 11 of the cats were viraemic at the same time; (2) from the effect of glutaraldehyde fixation of the FL-74 cells on the reaction with cat sera and the results of blocking experiments, it could be concluded that cat sera and rabbit anti-FeLV sera react partly with different antigenic specificities of FeLV, partly with the same antigens; and (3) the indirect membrane immunofluorescence test using FL-74 cells as target is not a good test to detect the presence of antibodies against feline oncornavirus-associated cell membrane antigen (FOCMA) because FL-74 cells produce a large quantity of FeLV and the fluorescence measured could be from antibodies against FeLV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-45-1-217
1979-10-01
2022-01-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/45/1/JV0450010217.html?itemId=/content/journal/jgv/10.1099/0022-1317-45-1-217&mimeType=html&fmt=ahah

References

  1. Calafat J., Buijs F., Hageman P. C., Links L., Hilgers J., Hekman A. 1974; Distribution of virus particles and mammary tumor antigens in mouse mammary tumours, transformed BALB/c mouse kidney cells and GR ascites leukemia cells. Journal of the National Cancer Institute 53:977–922
    [Google Scholar]
  2. Charman H. P., Kim N., Gilden R. V., Hardy W. D. Jun, Essex M. 1976; Humoral immune responses of cats to feline leukemia virus: comparison of responses to the major structural protein P30 and to a virus-specific cell membrane antigen (FOCMA). Journal of the National Cancer Institute 56:859–861
    [Google Scholar]
  3. Cotter S. M., Essex M., Hardy W. D. Jun 1974; Serologic studies of normal and leukemic cats in a multiple case leukemia cluster. Cancer Research 34:1061–1069
    [Google Scholar]
  4. Crandell R. A., Fabricant C. G., Nelson-Rees W. A. 1973; Development, characterization and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In vitro 9:176–185
    [Google Scholar]
  5. Daams J. H. 1970; Immunofluorescence studies on the biology of the mouse mammary tumour virus. In Immunity and Tolerance in Oncogenesis International Conference on Cancer Perugia, Italy: pp 463–474 Edited by Severi L.
    [Google Scholar]
  6. Essex M., Klein G., Snyder S. P., Harold J. B. 1971a; Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus. Nature, London 233:195–196
    [Google Scholar]
  7. Essex M., Klein O., Snyder S. P., Harold J. B. 1971b; Antibody to feline oncornavirus-associated cell membrane antigen in neonatal cats. International Journal of Cancer 8:384–390
    [Google Scholar]
  8. Essex M., Jakowski R. M., Hardy Jun W. D., Cotter S. M., Hess P., Sliski A. 1975; Feline oncornavirus-associated cell membrane antigen. III. Antibody titres in cats from leukemia cluster households. Journal of the National Cancer Institute 54:637–641
    [Google Scholar]
  9. Hardy W. D., Hirshaut Y., Hess P. 1973; Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. In Unifying Concepts of Leukemia, Bibliotheca Haemato-logica vol 39: pp 778–799 Edited by Dutcher R. M., L. Chieco-Bianchi. Basel: Karger;
    [Google Scholar]
  10. Hopwood D. 1972; Theoretical and practical aspects of glutaraldehyde fixation. Histochemical Journal 4:267–303
    [Google Scholar]
  11. Jarrett W. F. H., Mackey L., Jarrett O., Laird H., Hood C. 1974; Antibody response and virus survival in cats vaccinated against feline leukemia. Nature, London 248:230–232
    [Google Scholar]
  12. Jarrett W. F. H., Jarrett O., Mackey L., Laird H., Hood C., Hay D. 1975; Vaccination against feline leukemia virus using a cell membrane antigen system. International Journal of Cancer 16:134–141
    [Google Scholar]
  13. Olsen R. G., Hoover E. A., Mathes L. E., Heding L., Schaller J. P. 1976; Immunization against feline oncornavirus disease using a killed tumor cell vaccine. Cancer Research 36:3642–3646
    [Google Scholar]
  14. Russell P. H., Jarrett O. 1978; The occurrence of feline leukaemia virus neutralising antibodies in cats. International Journal of Cancer 22:351–357
    [Google Scholar]
  15. Sliski A. H., Essex M., Meyer C., Todaro G. 1977; Feline oncornavirus-associated cell membrane antigen: expression in transformed non-producer mink cells. Science 196:1336–1339
    [Google Scholar]
  16. Snyder S. P., Theilen G. H., Richards W. P. C. 1970; Morphological studies on transmissible feline fibrosarcoma. Cancer Research 30:1658–1667
    [Google Scholar]
  17. Stephenson J. R., Essex M., Hino S., Hardy W. D. Jun, Aaronson S. A. 1977; Feline oncornavirus-associated cell-membrane antigen (FOCMA): Distinction between FOCMA and the major virion glycoprotein. Proceedings of the National Academy of Sciences of the United States of America 74:1219–1223
    [Google Scholar]
  18. Theilen G. H., Kawakami T. G., Rush J. D., Munn R. J. 1969; Replication of cat leukemia virus in cell suspension cultures. Nature, London 222:589–590
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-45-1-217
Loading
/content/journal/jgv/10.1099/0022-1317-45-1-217
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error